Patent details
EP1827468
Title:
Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
Basic Information
- Publication number:
- EP1827468
- PCT Application Number:
- PCT/US/2005/024656
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP057712739
- PCT Publication Number:
- WO/2006/071274
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
- French Title of Invention:
- Inhibiteurs de l'acetylcholinesterase et acétate de leuprolide pour le traitement de la maladie d'Alzheimer
- German Title of Invention:
- Acetylcholinesterasehemmer und Leuprolidacetat zur Behandlung von Alzheimer-Krankheit
- SPC Number:
-
Dates
- Filing date:
- 13/07/2005
- Grant date:
- 22/08/2012
- EP Publication Date:
- 22/08/2012
- PCT Publication Date:
- 06/07/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/09/2007
- EP B1 Publication Date:
- 22/08/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/07/2013
- Expiration date:
- 13/07/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/07/2005
-
-
- Name:
- Curaxis Pharmaceutical Corporation
- Address:
- 1004 Chagford Way, Raleigh, NC 27614, United States (US)
Inventor
1
- Name:
- GREGORY Christopher, W.
- Address:
- United States (US)
2
- Name:
- SMITH Patrick, S.
- Address:
- United States (US)
Priority
- Priority Number:
- 638123 P
- Priority Date:
- 23/12/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61P 25/28;
| Filing date |
Document type |
Number of pages |